BioCentury
ARTICLE | Company News

Diversa joint venture with Dow

June 29, 2000 7:00 AM UTC

DVSA and DOW formed a 50-50 joint venture to develop industrial enzymes. The venture will contract with DVSA for enzyme discovery and evolution, and will contract with DOW for optimized strains, expression and product development and manufacturing. DVSA will receive fees and R&D payments, and will contribute product candidates to the venture. ...